L. Robillard

发表

G protein specificity: traffic direction required.

P. Albert, L. Robillard, 2002, Cellular signalling.

Comparison of four enzyme immunoassays for the detection of cytomegalovirus IgG antibodies.

L. Robillard, L. Pedneault, J. Joncas, 1993, Clinical and diagnostic virology.

Gbetagamma subunit combinations differentially modulate receptor and effector coupling in vivo.

T. Hébert, L. Robillard, N. Éthier, 2000, Cellular signalling.

Gβγ subunit combinations differentially modulate receptor and effector coupling in vivo

T. Hébert, L. Robillard, N. Éthier, 2000 .

Regulation of α5β1 integrin conformation and function by urokinase receptor binding

J. Xiong, M. Humphries, R. Czekay, 2005, The Journal of cell biology.

Murine Cathepsin F Deficiency Causes Neuronal Lipofuscinosis and Late-Onset Neurological Disease

H. Chapman, S. Mole, L. Robillard, 2006, Molecular and Cellular Biology.

The Multi-Kinase Inhibitor Lucitanib Enhances the Antitumor Activity of Coinhibitory and Costimulatory Immune Pathway Modulators in Syngeneic Models

M. Liao, T. Harding, L. Robillard, 2022, Journal of immunotherapy.

Urokinase Receptors Are Required for α5β1 Integrin-mediated Signaling in Tumor Cells*

H. Chapman, Ying-Ying Wei, L. Robillard, 2006, Journal of Biological Chemistry.

Urokinase receptors are required for alpha 5 beta 1 integrin-mediated signaling in tumor cells.

H. Chapman, Ying-Ying Wei, L. Robillard, 2007, The Journal of biological chemistry.

Multimodal microvascular imaging reveals that selective inhibition of class I PI3K is sufficient to induce an antivascular response.

N. van Bruggen, H. Koeppen, L. Friedman, 2013, Neoplasia.

Abstract 2475:In vitroandin vivoassessment of the mechanism of action of the PARP inhibitor rucaparib

T. Harding, L. Robillard, A. Simmons, 2017 .

Growth Hormone-induced Diacylglycerol and Ceramide Formation via Gαi3 and Gβγ in GH4 Pituitary Cells

P. Albert, Gele Liu, L. Robillard, 2002, The Journal of Biological Chemistry.

Secondary Somatic Mutations Restoring RAD51C and RAD51D Associated with Acquired Resistance to the PARP Inhibitor Rucaparib in High-Grade Ovarian Carcinoma.

James X. Sun, A. Tinker, D. Bowtell, 2017, Cancer discovery.

Kondrashova, O. et al. (2017) Secondary somatic mutations restoring RAD51C and RAD51D associated with acquired resistance to the PARP inhibitor rucaparib in high-grade ovarian carcinoma. Cancer

Swisher, James X. Sun, A. Tinker, 2017 .

Aurora kinase A drives the evolution of resistance to third generation EGFR inhibitors in lung cancer

Sourav Bandyopadhyay, V. Wang, F. McCormick, 2018, Nature Medicine.

Alveolar epithelial cell mesenchymal transition develops in vivo during pulmonary fibrosis and is regulated by the extracellular matrix

D. Sheppard, P. Wolters, H. Chapman, 2006, Proceedings of the National Academy of Sciences.

Abstract 3650: Preclinical evaluation of the PARP inhibitor rucaparib in combination with PD-1 and PD-L1 inhibition in a syngeneic BRCA1 mutant ovarian cancer model

S. Orsulic, M. Raponi, T. Harding, 2017 .

Comparison of a whole-virus enzyme immunoassay (EIA) with a peptide-based EIA for detecting rubella virus immunoglobulin G antibodies following rubella vaccination

L. Robillard, L. Pedneault, M. Zrein, 1993, Journal of clinical microbiology.

Quantitative phosphoproteomic analysis of the PI3K‐regulated signaling network

F. Gnad, M. Belvin, G. Hatzivassiliou, 2016, Proteomics.

Nasopharyngeal carcinoma and Burkitt's lymphoma in a Canadian family. I. HLA typing, EBV antibodies and serum immunoglobulins.

L. Robillard, J. Menezes, J. Joncas, 1976, Canadian Medical Association journal.

Aurora kinase A drives the evolution of resistance to third generation EGFR inhibitors in lung cancer

Sourav Bandyopadhyay, V. Wang, F. McCormick, 2018, Nature Medicine.

Differential desensitization of dopamine D2 receptor isoforms by protein kinase C: the importance of receptor phosphorylation and pseudosubstrate sites.

P. Albert, S. Morris, M. Daigle, 2007, European journal of pharmacology.

Comparison of novel synthetic peptide-based DETECT-RUBELLA enzyme immunoassays with Enzygnost and IMx for detection of rubella-specific immunoglobulin G

L. Robillard, L. Pedneault, M. Zrein, 1994, Journal of clinical microbiology.

Preclinical evaluation of the PARP inhibitor rucaparib in combination with PD-1 and PD-L1 inhibition in a syngeneic BRCA1 mutant ovarian cancer model

S. Orsulic, M. Raponi, T. Harding, 2017 .

Gβ Residues That Do Not Interact with Gα Underlie Agonist-independent Activity of K+ Channels*

T. Hébert, D. Logothetis, L. Robillard, 2002, The Journal of Biological Chemistry.

Abstract 3888: Intracranial evaluation of the in vivo pharmacokinetics, brain distribution, and efficacy of rucaparib inBRCA-mutant, triple-negative breast cancer

T. Harding, L. Robillard, Jim J. Xiao, 2019, Experimental and Molecular Therapeutics.

mTOR kinase inhibitor potentiates apoptosis of PI3K and MEK inhibitors in diagnostically defined subpopulations.

M. Belvin, L. Friedman, Kui Lin, 2012, Cancer letters.

Gbeta residues that do not interact with Galpha underlie agonist-independent activity of K+ channels.

T. Hébert, D. Logothetis, L. Robillard, 2002, Journal of Biological Chemistry.

Validation of respiratory syncytial virus enzyme immunoassay and shell vial assay results

L. Robillard, L. Pedneault, J. Turgeon, 1994, Journal of clinical microbiology.

Giant cell pneumonia due to respiratory syncytial virus. Occurrence in severe combined immunodeficiency syndrome.

N. Lapointe, L. Robillard, G. Delage, 1984, Archives of pathology & laboratory medicine.

Fibroblast activation protein targeted radiotherapy induces an immunogenic tumor microenvironment and enhances the efficacy of PD-1 immune checkpoint inhibition

J. Ungewiss, T. Harding, L. Robillard, 2023, European Journal of Nuclear Medicine and Molecular Imaging.